Sign in
Taking peoplePhase 3

Treatment of Pediatric Post-traumatic Stress Disorder With Memory Reactivation Under the Influence of Propranolol

Key facts

Who runs it
University Hospital, Toulouse
Where
France1 site in 1 countryChoose a country to see its sites
Status
Recruiting
Phase
Phase 3
People taking part
92 people, planned
Started
1 Feb 2023
Expected to end
Sept 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Propranolol Oral Product
  • Placebo
  • memory reactivation
Record updated
28 August 2023

Who can take part

Age
7 years to 12 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 25 criteriaShow less

Who can take part

  • Children aged 7-12 years
  • CPTS-RI total score ≥40
  • Primary diagnosis of PTSD (6 months or more after the traumatic event)
  • Heart rate ≥ 55 bpm
  • Systolic blood pressure ≥ 95 mm Hg
  • Affiliation to a social security scheme
  • Written consent signed by the parents/holders of parental authority and the investigator
  • Acceptance of the protocol by the child-Child and Parents/Holders of parental authority fluent in French

Who cannot take part

  • Concurrent medication with possible interactions with propranolol (cf 8.2)
  • Concurrent psychotropic drugs that have been shown to be effective in improving symptoms of PTSD (Antidepressants, atypical antipsychotics, mood stabilizers)
  • Concurrent psychotherapy (>1 structured session/month declared by the clinician who follows the child)
  • Currently treated with a bradycardic drug
  • Concurrent participation to another interventional study
  • Contraindication to propranolol (cardiogenic shock, sinus bradycardia, hypotension (< fifth percentile oscillometric or <2SD) (Banker et al., 2016 - see APPENDIX 1), greater than first-degree heart block, heart failure, bronchial asthma and hypersensitivity to propranolol hydrochloride)
  • Current active psychosis, anorexia nervosa, bulimia nervosa, binge-eating disorder, attention-deficit hyperactivity disorder, autism spectrum disorder
  • Obsessive-compulsive disorders
  • Bipolar Disorders
  • Renal or Hepatic Impairment
  • Age<7 years or ≥13 years
  • Children whose parents have been deprived of their authority
  • Children with psoriasis
  • Children with a predisposition to hypoglycemia
  • Mental retardation,
  • Traumatic brain injury (loss of consciousness > 10 minutes)
  • Pregnancy

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 7 and 12 years old?

This trial is currently available in France.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

By age 18, roughly 8% of traumatized youth have met criteria for a diagnosis of PTSD, with numbers rising up to 40% in cases of sexual abuse and assault. To date there is no empirical support for the use of psychopharmacological interventions as treatment of pediatric PTSD. Trauma-focused psychotherapeutic/TFP approaches should be favored in childhood PTSD. However, when compared to active control conditions, TFP produced a mean effect size on child and adolescents population (g=0.83). Moreover, in therapies with a substantial exposure component, the intense and lengthy reexperiencing of the traumatic event results in a substantial proportion of participants dropping out.

Read full original descriptionShow less

The reactivation of a previously consolidated memory can make it labile, subsequently requiring a re-stabilization of it called reconsolidation of the memory.

Acting on these reconsolidation processes makes possible to interfere with the subsequent storage of this memory.

The 2 groups in the trial

  • PropranololTreatment being tested

    Patient will receive oral propranolol

    Treatment: Propranolol Oral Product and memory reactivation

  • PlaceboPlacebo, for comparison

    Patient will receive oral placebo

    Treatment: Placebo and memory reactivation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Treatment of Pediatric Post-traumatic Stress Disorder With Memory Reactivation Under the Influence of Propranolol: A Randomized Placebo-controlled Trial. PPP
Criteria questions
Built from NCT04985344, who can take part
Record updated
28 August 2023